MiRNA 221-3p binding to CDKN1C, demonstrated in glioblastoma [29] and thyroid papillary carcinomas [30] cells, respectively, may also play a role in cell cycle progression in the setting of myocyte proliferation in the setting of myocardial ischemia. The gene discussed is CDKN1C; the disease is glioblastoma.